Abstract
Purpose
This study aimed to assess the incidence, potential risk factors and clinical impact of incomplete device endothelialization(IDE) after left atrial appendage closure (LAAC).
Methods
A total of 101 consecutive patients with nonvalvular atrial fibrillation (AF) who underwent successful LAAC and received antithrombotic treatment using a standard regimen were prospectively followed up to 6 months after the procedure. The status of device endothelialization and device-related thrombus (DRT) were evaluated using cardiac computed tomography (CT). Major adverse cardio-cerebral events (MACCE) including all-cause death, heart failure(HF) hospitalization, acute ischemic stroke, transient ischemic attack(TIA), peripheral vascular embolism, and major bleeding were recorded.
Results
IDE was detected in 65 (64.4%) patients. Patients with IDE or complete device endothelialization (CDE) did not significantly differ with respect to baseline clinical characteristics and interventional procedure features. Multivariate analysis model revealed that persistent AF, left atrial appendage ostial diameter and left atrial size were independent risk factors for IDE. During 6-month follow-up, the incidence of DRT was 4.6% in patients with IDE and 2.8% in those with CDE, respectively (p > 0.05), and the overall rate of MACCE was non-significantly higher in the IDE group (7.7% vs. 2.8%, p = 0.32).
Conclusion
IDE is common after LAAC, especially in patients with persistent AF, higher left atrial appendage ostial diameter and left atrial size. IDE confers an increased risk for DRT, but may be not necessarily associated with thromboembolic events and poor clinical outcome, providing careful monitoring and continued antithrombotic therapy are given.
Similar content being viewed by others
References
Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, Boriani G, Castella M, Dan GA, Dilaveris PE et al (2021) 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 42(5):373–498
Collado FMS, von Lama CM, Anderson CK, Madan N, Suradi HS, Huang HD, Jneid H, Kavinsky CJ (2021) Left Atrial Appendage Occlusion for Stroke Prevention in Nonvalvular Atrial Fibrillation. J Am Heart Assoc 10(21):e022274
Cresti A, García-Fernández MA, Sievert H, Mazzone P, Baratta P, Solari M, Geyer A, De Sensi F, Limbruno U (2019) Prevalence of extra-appendage thrombosis in non-valvular atrial fibrillation and atrial flutter in patients undergoing cardioversion: a large transoesophageal echo study. EuroIntervention 15(3):e225–e230
Cimmino G, Loffredo FS, Gallinoro E, Prozzo D, Fabiani D, Cante L, Salerno G, Cappelli Bigazzi M, Golino P (2021) : Percutaneous Left Atrial Appendage Occlusion: An Emerging Option in Patients with Atrial Fibrillation at High Risk of Bleeding.Medicina (Kaunas)57(5)
Collado FMS, Lama von Buchwald CM, Anderson CK, Madan N, Suradi HS, Huang HD, Jneid H, Kavinsky CJ (2021) : Left Atrial Appendage Occlusion for Stroke Prevention in Nonvalvular Atrial Fibrillation.Journal of the American Heart Association10(21)
Nielsen-Kudsk JE, Korsholm K, Damgaard D, Valentin JB, Diener HC, Camm AJ, Johnsen SP (2021) Clinical Outcomes Associated With Left Atrial Appendage Occlusion Versus Direct Oral Anticoagulation in Atrial Fibrillation. JACC Cardiovasc Interv 14(1):69–78
Yu J, Bai Y, Jiang LS (2021) Device related thrombus after left atrial appendage closure: State of the art. Pacing Clin Electrophysiol 44(7):1253–1258
Wazni O, Saliba W, Hussein AA (2021) Device-Related Thrombus After Left Atrial Appendage Occlusion. J Am Coll Cardiol 78(4):314–316
Saw J, Nielsen-Kudsk JE, Bergmann M, Daniels MJ, Tzikas A, Reisman M, Rana BS (2019) Antithrombotic Therapy and Device-Related Thrombosis Following Endovascular Left Atrial Appendage Closure. JACC Cardiovasc Interv 12(11):1067–1076
Fauchier L, Cinaud A, Brigadeau F, Lepillier A, Pierre B, Abbey S, Fatemi M, Franceschi F, Guedeney P, Jacon P et al (2018) Device-Related Thrombosis After Percutaneous Left Atrial Appendage Occlusion for Atrial Fibrillation. J Am Coll Cardiol 71(14):1528–1536
Kim YJ, Park SJ, Shin SY, Hong J (2021) Removed 5-Year-Old Amulet Device: Triplet of Peridevice Leakage, Poor Endothelialization, and Device-Related Thrombus. JACC Cardiovasc Interv 14(21):2405–2406
Prosperi-Porta G, Schnell G, Colbert J, Franko A, Wilton SB, Kuriachan VP (2018) : Multiple Thromboembolic Events from a Left Atrial Appendage Occlusion Device. Can J Cardiol34(3):342.e313-342.e315
Sharma SP, Singh D, Nakamura D, Gopinathannair R, Lakkireddy D (2019) Incomplete endothelialization of WatchmanTM Device: Predictors and Implications from Two Cases. J Atr Fibrillation 11(5):2162
Kar S, Hou D, Jones R, Werner D, Swanson L, Tischler B, Stein K, Huibregtse B, Ladich E, Kutys R et al (2014) Impact of Watchman and Amplatzer devices on left atrial appendage adjacent structures and healing response in a canine model. JACC Cardiovasc Interv 7(7):801–809
Schwartz RS, Holmes DR, Van Tassel RA, Hauser R, Henry TD, Mooney M, Matthews R, Doshi S, Jones RM, Virmani R (2010) Left atrial appendage obliteration: mechanisms of healing and intracardiac integration. JACC Cardiovasc Interv 3(8):870–877
Reddy VY, Doshi SK, Kar S, Gibson DN, Price MJ, Huber K, Horton RP, Buchbinder M, Neuzil P, Gordon NT et al (2017) 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials. J Am Coll Cardiol 70(24):2964–2975
Batnyam U, Tuluca A, Witzke CF, Greenspan AM, Mainigi SK (2021) : Failure of Complete Endothelialization of a Watchman Device 3 Years Post-Implantation. JACC Case Rep3(2):319–321
Massarenti L, Yilmaz A (2012) Incomplete endothelialization of left atrial appendage occlusion device 10 months after implantation. J Cardiovasc Electrophysiol 23(12):1384–1385
Xu J, Gong X, Chen C, Xing J, Wang Q, Shen W, Zhang Q (2021) Reduced plasma level of basic fibroblast growth factor is associated with incomplete device endothelialization at six months following left atrial appendage closure. BMC Cardiovasc Disord 21(1):242
Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, Mullin CM, Sick P (2009) Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet 374(9689):534–542
Huang H, Liu Y, Xu Y, Wang Z, Li Y, Cao K, Zhang S, Yang Y, Yang X, Huang D et al (2017) Percutaneous Left Atrial Appendage Closure With the LAmbre Device for Stroke Prevention in Atrial Fibrillation: A Prospective, Multicenter Clinical Study. JACC Cardiovasc Interv 10(21):2188–2194
Chen M, Wang ZQ, Wang QS, Sun J, Zhang PP, Feng XF, Li W, Yu Y, Liu B, Mo BF et al (2020) One-stop strategy for treatment of atrial fibrillation: feasibility and safety of combining catheter ablation and left atrial appendage closure in a single procedure. Chin Med J (Engl) 133(12):1422–1428
Reddy VY, Doshi SK, Kar S, Gibson DN, Price MJ, Huber K, Horton RP, Buchbinder M, Neuzil P, Gordon NT et al (2017) 5-Year Outcomes After Left Atrial Appendage Closure From the PREVAIL and PROTECT AF Trials. J Am Coll Cardiol 70(24):2964–2975
Eckel RH, Cornier MA (2014) Update on the NCEP ATP-III emerging cardiometabolic risk factors. BMC Med 12:115
Tzikas A, Holmes DR Jr, Gafoor S, Ruiz CE, Blomström-Lundqvist C, Diener HC, Cappato R, Kar S, Lee RJ, Byrne RA et al (2017) Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints, and data collection requirements for clinical studies. Europace 19(1):4–15
Saw J, Fahmy P, DeJong P, Lempereur M, Spencer R, Tsang M, Gin K, Jue J, Mayo J, McLaughlin P et al (2015) Cardiac CT angiography for device surveillance after endovascular left atrial appendage closure. Eur Heart J Cardiovasc Imaging 16(11):1198–1206
Sivasambu B, Arbab-Zadeh A, Hays A, Calkins H, Berger RD (2019) Delayed endothelialization of watchman device identified with cardiac CT. J Cardiovasc Electrophysiol 30(8):1319–1324
Angelillis M, Gargiulo G, Moschovitis A, Fürholz M, Shakir S, Piazza N, Räber L, Meier B, Gloekler S, Windecker S et al (2018) Computed tomography detection and quantification of left atrial appendage residual patency as collateral finding after percutaneous closure. Int J Cardiol 260:42–46
Saw J, Lopes JP, Reisman M, McLaughlin P, Nicolau S, Bezerra HG (2016) : Cardiac Computed Tomography Angiography for Left Atrial Appendage Closure.Canadian Journal of Cardiology32(8)
Agudelo VH, Millán X, Li CH, Moustafa AH, Asmarats L, Serra A, Arzamendi D (2021) Prevalence, mechanisms and impact of residual patency and device-related thrombosis following left atrial appendage occlusion: a computed tomography analysis. EuroIntervention 17(11):e944–e952
Ben-Yehuda O, Redfors B (2016) Validation of the Bleeding Academic Research Consortium Bleeding Definition Towards a Standardized Bleeding Score. J Am Coll Cardiol 67(18):2145–2147
Granier M, Laugaudin G, Massin F, Cade S, Winum PF, Freitag C, Pasquie JL (2018) Occurrence of Incomplete Endothelialization Causing Residual Permeability After Left Atrial Appendage Closure. J Invasive Cardiol 30(7):245–250
Lindner S, Behnes M, Wenke A, Sartorius B, Akin M, Mashayekhi K, Gawlitza J, Weidner KJ, Ansari U, Haubenreisser H et al (2021) Incomplete neo-endothelialization of left atrial appendage closure devices is frequent after 6 months: a pilot imaging study. Int J Cardiovasc Imaging 37(7):2291–2298
Zhao MZ, Chi RM, Yu Y, Wang QS, Sun J, Li W, Zhang PP, Liu B, Feng XF, Zhao Y et al (2021) Value of detecting peri-device leak and incomplete endothelialization by cardiac CT angiography in atrial fibrillation patients post Watchman LAAC combined with radiofrequency ablation. J Cardiovasc Electrophysiol 32(10):2655–2664
Galea R, Gräni C (2021) Device neo-endothelialization after left atrial appendage closure: the role of cardiac computed tomography angiography. Int J Cardiovasc Imaging 37(7):2299–2301
Cochet H, Iriart X, Sridi S, Camaioni C, Corneloup O, Montaudon M, Laurent F, Selmi W, Renou P, Jalal Z et al (2018) Left atrial appendage patency and device-related thrombus after percutaneous left atrial appendage occlusion: a computed tomography study. Eur Heart J Cardiovasc Imaging 19(12):1351–1361
Aune D, Sen A, Schlesinger S, Norat T, Janszky I, Romundstad P, Tonstad S, Riboli E, Vatten LJ (2017) Body mass index, abdominal fatness, fat mass and the risk of atrial fibrillation: a systematic review and dose-response meta-analysis of prospective studies. Eur J Epidemiol 32(3):181–192. https://doi.org/10.1007/s10654-017-0232-4
Acknowledgements
Not applicable.
Funding
This study was supported by Top-level Clinical Discipline Project of Shanghai Pudong District Grant(PWYgf2021-01), Training plan for discipline leaders of Shanghai Pudong New Area Health Commission Grant(PWRd2020-09), Programs of National Natural Science Foundation of China (82000378 and 82170477).
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by JX, CZC, JX, LW and YRT. The first draft of the manuscript was written by JX and CZC. BY and QZ conducted a critical revision of manuscript. YLS and JQH was responsible for the revision of the manuscript for important intellectual content. All authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the principles of the declaration of Helsinki and was approved by the hospital ethics committee.
Consent to participate
All patients provided their written informed consents.
Consent for publication
Consent for publication was obtained for every individual person’s data included in the study.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Jing Xu and Chuan Zhi Chen contributed equally to this study.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Xu, J., Chen, C.Z., Xing, J. et al. Clinical relevance of incomplete device endothelialization after left atrial appendage closure. Int J Cardiovasc Imaging 39, 451–459 (2023). https://doi.org/10.1007/s10554-022-02721-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10554-022-02721-w